News from MedImmune A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

26 Jul, 2013, 10:01 ET MedImmune's FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal), Four-Strain, Nasal-Spray Flu Vaccine, Ships for 2013-2014 Influenza Season

MedImmune, the global biologics research and development arm of AstraZeneca, announced today that it began shipping FluMist Quadrivalent to...


04 May, 2013, 10:00 ET MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting

 MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E....


17 Dec, 2012, 09:00 ET MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections

 MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals,...


19 Oct, 2012, 15:00 ET MedImmune To Present Three Influenza Abstracts At The IDWeek 2012 Meeting

 MedImmune, the global biologics arm of AstraZeneca, announced today it will present three influenza abstracts at IDWeek 2012: the first...


09 Oct, 2012, 11:30 ET MedImmune To Present Four Flu Abstracts At The Influenza Vaccines For The World Conference

 MedImmune, the global biologics arm of AstraZeneca, announced today it will present four abstracts at the Influenza Vaccines for the World...


09 Oct, 2012, 09:00 ET MedImmune Joins Forces With Leading Cancer Organizations to Advance Novel Immunotherapy Research

 The Cancer Research Institute (CRI), the Ludwig Institute for Cancer Research and MedImmune, the global biologics arm of AstraZeneca, today...


03 Oct, 2012, 12:30 ET Study In Journal of Medical Economics Shows Palivizumab Cost Effectiveness Using FDA-approved Dosing And AAP Red Book

MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis®...


10 Sep, 2012, 06:00 ET MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market

 MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outsourcing company, today announced...


02 Aug, 2012, 10:30 ET FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping For 2012-2013 Influenza Season

MedImmune, the global biologics arm of AstraZeneca, announced it began shipping FluMist® to influenza vaccine distributors throughout the...


10 Jul, 2012, 10:00 ET MedImmune And KaBOOM! Team Up To Build New Playground At The Children's Inn At NIH

 Summer is a time to play and July 23rd is when The Children's Inn at NIH will get a fabulous new playground thanks to the generosity of...


01 May, 2012, 10:44 ET New Study Demonstrates Dosing Non-Compliance Increases RSV-Related Hospitalizations Among High-Risk Babies In Medicaid Population

MedImmune, the global biologics arm of AstraZeneca, announced results from a new retrospective database cohort study of 8,443 high-risk infants...


26 Mar, 2012, 10:00 ET MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference

MedImmune announced today it will present nine abstracts at the National Immunization Conference Online (NIC Online), from March 26 – 28,...


29 Feb, 2012, 19:20 ET MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)

 MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist® Quadrivalent (Influenza Vaccine Live,...


14 Nov, 2011, 11:00 ET MedImmune Announces Winners of Its 6th Annual Global Abstract Competition

MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific...


08 Nov, 2011, 07:00 ET MedImmune Manufacturing Facility Recognized as 2011 Facility of the Year in Pharmaceutical Engineering

MedImmune, the global biologics arm of AstraZeneca, today announced that the company's expansion project at its Frederick, Md., Manufacturing...


03 Nov, 2011, 11:19 ET MedImmune annonce les vainqueurs de son concours européen de résumés de recherche sur le cancer

?MedImmune a dévoilé aujourd'hui les noms des lauréats de son concours européen annuel de résumés de recherche sur...


03 Nov, 2011, 11:16 ET MedImmune annuncia i vincitori del concorso European Cancer Research Abstract Competition

?Oggi edImmune ha annunciato i vincitori del concorso European Cancer Research Abstract Competition che premia ricerche importanti condotte da...


03 Nov, 2011, 11:13 ET MedImmune gibt Gewinner des europäischen Forschungswettbewerbs für Abstracts im Bereich Krebsforschung bekannt

?MedImmune gab heute die Gewinner seines alljährlich stattfindenden europäischen Wettbewerbs bekannt, in dessen Rahmen herausragende...


02 Nov, 2011, 14:13 ET MedImmune anuncia los ganadores de la European Cancer Research Abstract Competition

MedImmune anunció hoy a los ganadores de su European Cancer Research Abstract Competition anual, que reconoce la investigación destacada...


21 Oct, 2011, 12:00 ET MedImmune to Present Phase 3 Pediatric Clinical Data for Quadrivalent Influenza at 49th Annual IDSA Meeting

BOSTON, Oct. 21, 2011 /PRNewswire/ -- MedImmune announced today it will present results of a Phase 3 pediatric clinical study of its...


13 Oct, 2011, 08:00 ET "When Will You Pick?"™ Campaign Encourages Families to Make Flu Vaccination a Priority This Fall

Families are busy enough during the back-to-school season – new class schedules, countless extracurricular activities, and daily homework...


03 Oct, 2011, 08:00 ET MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer

MedImmune, the global biologics arm of AstraZeneca, today announced execution of an in-licensing agreement with Pfizer Inc for tremelimumab...


18 Jul, 2011, 12:00 ET FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping for 2011-2012 Influenza Season

MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who...


18 Jul, 2011, 06:00 ET MedImmune Submits Supplemental Biologics License Application for Quadrivalent Seasonal Nasal Spray Influenza Vaccine

MedImmune has received confirmation from the U.S. Food & Drug Administration (FDA) that the Agency has filed the Company's supplemental...


13 May, 2011, 10:00 ET MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference

MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18,...